These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 186222

  • 1. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M.
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [Abstract] [Full Text] [Related]

  • 2. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M, Gunven P.
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [Abstract] [Full Text] [Related]

  • 3. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G, Dewey F, Klein G, Henle G, Henle W.
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [Abstract] [Full Text] [Related]

  • 4. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T, Mizuno F, Osato T.
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [Abstract] [Full Text] [Related]

  • 5. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K, Harada M, Sairenji T, Hinuma Y.
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 10. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S.
    Hokkaido Igaku Zasshi; 1990 Sep 04; 65(5):481-92. PubMed ID: 2172132
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M, Stefanescu I, Blagdon M, Menezes J.
    J Infect Dis; 1994 Dec 04; 170(6):1439-47. PubMed ID: 7995983
    [Abstract] [Full Text] [Related]

  • 12. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May 04; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 13. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov 04; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 14. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov 04; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 15. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA.
    J Immunol; 1978 Oct 04; 121(4):1239-44. PubMed ID: 81224
    [Abstract] [Full Text] [Related]

  • 16. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T.
    Hokkaido Igaku Zasshi; 1981 Nov 04; 56(6):587-96. PubMed ID: 6175556
    [Abstract] [Full Text] [Related]

  • 17. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Nov 04; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 18. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan 04; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

  • 19. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM.
    J Infect Dis; 1999 May 04; 179(5):1108-15. PubMed ID: 10191211
    [Abstract] [Full Text] [Related]

  • 20. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec 04; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.